NeuroscienceNeuropsychopharmacologyPeer-reviewed
Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model
Emily Z. Huie, Xin Yang, Mengia S. Rioult-Pedotti…·John J Marshall
The paper evaluates peptidomimetic inhibitors targeting TrkB/PSD-95 signaling in an Angelman Syndrome mouse model, showing improved seizure outcomes and cognition but not motor function.
8 citations